RESOURCES
Browse our content
Articles
Potency Under the Microscope: What Regulators Expect from RNA and Gene Therapies Today
April 23, 2025
White Papers
Enhancing In-Process Control Testing in Adenoviral Production Using Multi-Angle Dynamic Light Scattering
April 9, 2025
Webinars
Nanopore Sequencing for RNA Vaccines and Therapeutics
April 2, 2025
Articles
Overcoming RNA Bottlenecks – Part 4: Advancing Analytical and QC Methods for RNA Therapeutics
March 31, 2025
Articles
Overcoming RNA Bottlenecks – Part 3: Achieving Consistent High Yields in High-Scale Manufacturing
March 25, 2025
Articles
Overcoming RNA Bottlenecks – Part 2: Navigating the Regulatory Path & CMC Challenges
March 13, 2025
Articles
Overcoming RNA Bottlenecks – Part 1: How to Ensure Consistent Formulation & Stability
March 6, 2025
Articles
The patient connection – How CDMOs enable patient-centric solutions
March 5, 2025
White Papers
Residual dsRNA testing by ELISA in mRNA vaccines
February 27, 2025
Articles
Revolutionizing Cancer Vaccines with RNA Technology: How RNA is Changing Personalized Medicine
January 9, 2025
Exciting News: Exothera Teams Up with Vaxthera on COVID-19 Vaccine Project
January 6, 2025
Posters
Navigating Pitfalls in the Adenovirus Development: From Drug discovery to Clinics and beyond
June 6, 2024
Posters
Revolutionizing mRNA Production: the paradigm-breaking Ntensify™ continuous-batch RNA system
May 23, 2024
Posters
Tackling AAV Manufacturing Process Industrialization Challenges Using A Standard Platform Approach
May 13, 2024
Webinars
Increasing efficiency in AAV-based gene therapy production: platform optimization with multiserotype AAV affinity capture
April 16, 2024
Articles
CDMO Exothera grows North American tech and footprint
April 8, 2024
Articles
Driving Innovation in Nucleic Acid Therapeutics
April 8, 2024
Webinars
How to achieve high titer cost-effective AAV production
February 6, 2024
Webinars
Proactive Strategies for Biotech Success in the 2024 Landscape
November 9, 2023
Posters
Online monitoring of cell growth and shape in transient transfection process for AAV production in stirred tank bioreactor
July 4, 2023
Posters
Seamless scale-up of transient transfection process for rAAV production from shake flask to manufacturing-scale bioreactor
June 9, 2023
Webinars
Joint webinar with Bio-Rad Laboratories – Droplet Digital PCR (ddPCR): A Versatile Tool for Absolute Quantification and Quality Analysis of Viral Vector
June 7, 2023
Webinars
Joint webinar with Univercells Technologies – From tech transfer to commercial scale viral manufacturing in 8 months – a CDMO case study
June 1, 2023
Posters
Suspension based adenovirus production in scale-X™️ fixed-bed bioreactor
March 23, 2023
Webinars
Joint webinar with Univercells Technologies – Simplifying Seed Train: A Benchtop System for Intensified Inoculation of Large-Scale Bioreactors
January 24, 2023
Posters
Design of Experiment, a powerful tool to simplify viral production process development
November 28, 2022
Videos
Critical decision to address during the viral vector manufacturing
September 21, 2022
Articles
How standardized viral vector platforms can drive better service from CDMOs
July 12, 2022
Webinars
Joint webinar with Pall Corporations – Pall’s Accelerator℠ Integrated Solutions: Supporting Exothera to meet the high demand for viral vector GMP manufacturing.
June 21, 2022
Podcasts
Using End-to-End Integrated Solutions to meet the High Demand for Viral Vector GMP Manufacturing
June 14, 2022
Webinars
Joint webinar with POLYPLUS – Taking a right first-time approach to optimize end-to-end viral vector manufacturing
June 9, 2022
Reports
Biopharma CDMO Benchmark Report – What customers want from their CDMO
April 15, 2022
Articles
Serum-based media concerns in viral vector manufacturing
March 15, 2022
Articles
Are modern scalable bioreactors the right cell culture strategy for gene and cell therapy success?
January 31, 2022
Articles
Gene and cell therapy manufacturing: how to design your stable cell line strategy?
January 5, 2022
Posters
Adaptation of suspension-based Adenovirus production process to scale-X™ technology
December 21, 2021
White Papers
The landscape for viral vector upstream processes – PROS and CONS
December 11, 2021
Infographics
Timeline of viral vector-based Cell & Gene therapy approvals
May 6, 2021
Infographics
Worldwide approved gene therapies based on viral vectors
February 21, 2021
Infographics
Plasmid manufacturing capacity around the world
November 30, 2020